Bearish MACD Crossovers – ADLR, DCTH, FASC, HAFC, INCTE

Apr 27th, 2011 | By | Category: Finance

Bearish MACD Crossovers – ADLR, DCTH, FASC, HAFC, INCTE

Adolor Corporation (NASDAQ:ADLR) fell -3.47%, to close at $1.39 and its overall traded volume was 219,097.00 shares in the last trading session. ADLR opened at $1.43 and is trading within the range of $1.39-$1.46. The stock has a 52 week low of $1.00 and 52 week high of $2.24. The market capitalization of the company stands at $64.53M and it has 46.43M outstanding shares.
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription pain management products. The Company’s product ENTEREG, is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company also has a number of product candidates in various stages of clinical and preclinical development. The Company is collaborating with Pfizer Inc. (Pfizer) in the clinical development of two delta opioid receptor agonist compounds: ADL5859 and ADL5747, for the treatment of pain. The Company also is clinically testing ADL7445 and ADL5945 to treat opioid bowel dysfunction (OBD), a condition that often results from chronic use of opioid analgesics to treat persistent pain conditions. Its other product candidates are in preclinical development for treating moderate-to-severe pain and other central nervous system conditions.


Delcath Systems, Inc. (NASDAQ:DCTH) fell -1.22%, to close at $7.27 and its overall traded volume was 1.15M shares in the last trading session. DCTH shares were trading within the range of $7.25-$7.60 while its opening price was $7.37. The 52-week range of the stock is $5.35 – $16.45. DCTH’s market capitalization is $312.45M and it has 42.98M outstanding shares.Delcath Systems, Inc. (Delcath) is a development-stage company that has developed a system designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body. The Company focuses on the development of its product, the Delcath Percutaneous Hepatic Perfusion System (the Delcath PHP System), which provides regional therapy by isolating the circulatory system of the liver in order to directly deliver high doses of therapeutic agents, while controlling the systemic exposure of those agents. The Delcath PHP System is minimally invasive and repeatable. In its initial application, the Delcath PHP System isolates the liver from the patient’s general circulatory system in order to deliver high doses of melphalan hydrochloride, an approved chemotherapeutic drug, directly to the liver.


First American Scientific Corp (OTC:FASC) percentage change fell -0.62%, to close at $0.0159 and its overall traded volume was 42,827.00 shares in the last trading session. FASC opened the day at $0.02, it made an intraday low of $0.01 and an intraday high of $0.02. The stock has a 52 week range of $0.00 – $0.05. The market capitalization of the company stands at $3.18M and it has 199.95M outstanding shares.First American Scientific Corp. owns the patented kinetic disintegration system called the KDS Micronex System and three additional process patents using the equipment. The System consists of an electrically powered disintegration/drying chamber and feeding system that utilize kinetic energy and standing sound waves to pulverize various waste materials such as biomass (wood waste), pulp sludge, animal waste, food waste, rubber, glass and other feed stocks into powders that can be used as a combustible fuel or a high nutrient fertilizer. It focuses on identifying and developing waste to resources strial applications for the KDS System, then market, manufacture, sell, lease and/or license it to end users in the forest and pulp and paper industries, in agriculture, in recycling and others. It has three subsidiaries: First American Scientific ( Canada ) Ltd., First American Scientific Corp. (Malaysia) Bhd. Sdn and JP FASKorea Co. Ltd.


Hanmi Financial Corp (NASDAQ:HAFC) percentage change dropped -0.76%, to close at $1.30 and its overall traded volume was 1.14M shares in the last trading session. HAFC opened the day at $1.31, it made an intraday low of $1.28 and an intraday high of $1.32. The stock has a 52 week low of $0.86 and 52 week high of $4.26. The market capitalization of the company stands at $196.64M and it has 151.26M outstanding shares.Hanmi Financial Corporation (Hanmi Financial) is a holding company for Hanmi Bank (the Bank). The Bank is a community bank conducting general business banking, with its primary market encompassing the Korean-American community, and other communities in the multi-ethnic populations of Los Angeles County, Orange County, San Bernardino County, San Diego County, the San Francisco Bay area, and the Silicon Valley area in Santa Clara County. The Bank provides its banking services through its branch network to a variety of small- to medium-sized businesses. As of December 31, 2009, the Bank had a branch network of 27 full-service branch offices in California and two loan production offices (LPOs) in Virginia and Washington. Its subsidiaries include Chun-Ha Insurance Services, Inc. and All World Insurance Services, Inc., which are insurance agencies offering a line of insurance products, including life, commercial, automobile, health, and property and casualty.


INNOCENT INC (OTC:INCTE) fell -17.65%, to close at $0.420 and its overall traded volume was 77,439.00 shares in the last trading session. INCTE opened at $0.47 and is trading within the range of $0.34-$0.47. The stock has a 52 week range of $0.20 – $1.19. At current market price, the market capitalization of the company stands at $8.40M and it has 20.00M outstanding shares.


Tags: , , , , ,

Leave a Comment